Common Stock, Shares, Outstanding of Citius Pharmaceuticals, Inc. from 30 Sep 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Citius Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Sep 2010 to 31 Dec 2025.
  • Citius Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 22,376,427, a 190% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Citius Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 22,376,427 +14,649,184 +190% 31 Dec 2025 10-Q 13 Feb 2026 2026 Q1
Q3 2025 18,067,744 +10,820,501 +149% 30 Sep 2025 10-Q 13 Feb 2026 2026 Q1
Q2 2025 14,475,029 -166,250,378 -92% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q3
Q1 2025 8,760,649 -150,334,132 -94% 31 Mar 2025 10-Q 14 May 2025 2025 Q2
Q4 2024 7,727,243 -151,239,333 -95% 31 Dec 2024 10-Q 14 Feb 2025 2025 Q1
Q3 2024 7,247,243 +892,872 +14% 30 Sep 2024 10-K 23 Dec 2025 2025 FY
Q2 2024 180,725,407 +21,867,609 +14% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q3
Q1 2024 159,094,781 +12,736,984 +8.7% 31 Mar 2024 10-Q 14 May 2024 2024 Q2
Q4 2023 158,966,576 +12,755,446 +8.7% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q1
Q3 2023 6,354,371 -139,856,759 -96% 30 Sep 2023 10-K 27 Dec 2024 2024 FY
Q2 2023 158,857,798 +12,728,168 +8.7% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q3
Q1 2023 146,357,797 +228,167 +0.16% 31 Mar 2023 10-Q 12 May 2023 2023 Q2
Q4 2022 146,211,130 +181,500 +0.12% 31 Dec 2022 10-Q 10 Feb 2023 2023 Q1
Q3 2022 146,211,130 +231,701 +0.16% 30 Sep 2022 10-K 29 Dec 2023 2023 FY
Q2 2022 146,129,630 +150,201 +0.1% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q3
Q1 2022 146,129,630 +11,428,411 +8.5% 31 Mar 2022 10-Q 12 May 2022 2022 Q2
Q4 2021 146,029,630 +90,452,634 +163% 31 Dec 2021 10-Q 10 Feb 2022 2022 Q1
Q3 2021 145,979,429 +90,402,433 +163% 30 Sep 2021 10-K 22 Dec 2022 2022 FY
Q2 2021 145,979,429 +99,663,131 +215% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q3
Q1 2021 134,701,219 +96,623,157 +254% 31 Mar 2021 10-Q 13 May 2021 2021 Q2
Q4 2020 55,576,996 +25,399,322 +84% 31 Dec 2020 10-Q 11 Feb 2021 2021 Q1
Q3 2020 55,576,996 +26,646,503 +92% 30 Sep 2020 10-K 15 Dec 2021 2021 FY
Q2 2020 46,316,298 +24,240,517 +110% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q3
Q1 2020 38,078,062 +19,432,702 +104% 31 Mar 2020 10-Q 14 May 2020 2020 Q2
Q4 2019 30,177,674 +12,378,883 +70% 31 Dec 2019 10-Q 13 Feb 2020 2020 Q1
Q3 2019 28,930,493 +12,731,702 +79% 30 Sep 2019 10-K 16 Dec 2020 2020 FY
Q2 2019 22,075,781 +11,398,559 +107% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q3
Q1 2019 18,645,360 +7,978,138 +75% 31 Mar 2019 10-Q 15 May 2019 2019 Q2
Q4 2018 17,798,791 +7,823,273 +78% 31 Dec 2018 10-Q 14 Feb 2019 2019 Q1
Q3 2018 16,198,791 +7,852,947 +94% 30 Sep 2018 10-K 16 Dec 2019 2019 FY
Q2 2018 10,677,222 +5,619,975 +111% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q3
Q1 2018 10,667,222 -64,837,020 -86% 31 Mar 2018 10-Q 11 May 2018 2018 Q2
Q4 2017 9,975,518 -64,137,542 -87% 31 Dec 2017 10-Q 14 Feb 2018 2018 Q1
Q3 2017 8,345,844 +3,469,973 +71% 30 Sep 2017 10-K 11 Dec 2018 2018 FY
Q2 2017 5,057,247 -67,980,813 -93% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q3
Q1 2017 75,504,242 +4,366,200 +6.1% 31 Mar 2017 10-Q 15 May 2017 2017 Q2
Q4 2016 74,113,060 +39,411,840 +114% 31 Dec 2016 10-Q 14 Feb 2017 2017 Q1
Q3 2016 4,875,871 -29,242,015 -86% 30 Sep 2016 10-K 13 Dec 2017 2017 FY
Q2 2016 73,038,060 +39,811,849 +120% 30 Jun 2016 10-Q 15 Aug 2016 2016 Q3
Q1 2016 71,138,042 +39,557,202 +125% 31 Mar 2016 10-Q 20 May 2016 2016 Q2
Q4 2015 34,701,220 +3,620,380 +12% 31 Dec 2015 10-Q 12 Feb 2016 2016 Q1
Q3 2015 34,117,886 +4,092,591 +14% 30 Sep 2015 10-K 23 Dec 2016 2016 FY
Q2 2015 33,226,211 +15,226,211 +85% 30 Jun 2015 10-Q 13 Aug 2015 2015 Q3
Q1 2015 31,580,840 +13,580,840 +75% 31 Mar 2015 10-Q 13 May 2015 2015 Q2
Q4 2014 31,080,840 +13,323,507 +75% 31 Dec 2014 10-Q 17 Feb 2015 2015 Q1
Q3 2014 30,025,295 +12,025,295 +67% 30 Sep 2014 10-K 14 Dec 2015 2015 FY
Q2 2014 18,000,000 0 0% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q3
Q1 2014 18,000,000 0 0% 31 Mar 2014 10-Q 15 May 2014 2014 Q2
Q4 2013 17,757,333 -242,667 -1.3% 31 Dec 2013 10-KT 29 Dec 2014 2014 FY
Q3 2013 18,000,000 0 0% 30 Sep 2013 10-Q 14 Aug 2014 2014 Q3
Q2 2013 18,000,000 0 0% 30 Jun 2013 10-Q 18 Sep 2013 2013 Q3
Q1 2013 18,000,000 0 0% 31 Mar 2013 10-Q 13 May 2013 2013 Q2
Q4 2012 18,000,000 0 0% 31 Dec 2012 10-Q 08 Feb 2013 2013 Q1
Q3 2012 18,000,000 0 0% 30 Sep 2012 10-K 06 Feb 2014 2013 FY
Q2 2012 18,000,000 0 0% 30 Jun 2012 10-Q 17 Aug 2012 2012 Q3
Q1 2012 18,000,000 31 Mar 2012 10-Q 11 May 2012 2012 Q2
Q4 2011 18,000,000 31 Dec 2011 10-Q 14 Feb 2012 2012 Q1
Q3 2011 18,000,000 0 0% 30 Sep 2011 10-K 15 Jan 2013 2012 FY
Q2 2011 18,000,000 30 Jun 2011 10-Q 26 Aug 2011 2011 Q3
Q3 2010 18,000,000 30 Sep 2010 10-K 13 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.